Kyorin Pharmaceutical

The corporate philosophy of the Kyorin Group is disseminated as 'Kyorin is committed to fulfilling its duty of valuing life and contributing to the improvement of health for the benefit of society, in order to bring joy to the patients and their families. We embarked on our full-scale operations on April 1, 2018, aiming to be a trusted drug manufacturer. In response to notable changes in the pharmaceutical sector, such as the overhaul of the NHI (National Health Insurance) drug pricing system, we integrated our production expertise developed as part of KYORIN Pharmaceutical.

Products & Services

Benzamide

Facilities For The Manufacturing Of Fleroxacin Bulk Drug Substance At The Okaya Plant In Nagano, Japan

Facilities for the Mfg of Fleroxacin Bulk Drug Substan

Chiyoda City